. 2013 Oct 16;8(10):e77559. doi: 10.1371/journal.pone.0077559

Table 1. Displays design of experimental groups of non- or pre-sensitization and the treatment characteristics.

Group	n	Skin for sensitization	Donor for HTx	PC61 (0.25mg, i.v.)	PCI (hrs)
G1	7(5) ^ξ	No	IL-6KO	No	No
G2	9(5) ^ξ	No	IL-6KO	Yes	No
G3	7(5) ^ξ	No	C57BL/6	No	No
G4	6(6) ^ξ	No	BALB/c	No	No
G5	3	BALB/c	C57BL/6	No	7.0±0.5
G6	4	BALB/c	IL-6KO	No	6.5±0.8

^ξ

The number in the parenthesis represents amount of transplant surgeries for survival curves among total surgeries (n).